Stock Earnings

Question 1

What are Paradigm Biopharmaceuticals Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Paradigm Biopharmaceuticals Ltd has a total asset of $24, Net loss of $-18

Question 2

What are the key financial ratios for PBIGF?

Accepted Answer

Paradigm Biopharmaceuticals Ltd's Current ratio is 8, has a Net margin is -257.14, sales per share of $0.01.

Question 3

How is Paradigm Biopharmaceuticals Ltd's revenue broken down by segment or geography?

Accepted Answer

Paradigm Biopharmaceuticals Ltd largest revenue segment is Pharmaceutical Drugs, at a revenue of 65,800 in the most earnings release.For geography, Australia is the primary market for Paradigm Biopharmaceuticals Ltd, at a revenue of 65,800.

Question 4

Is Paradigm Biopharmaceuticals Ltd profitable?

Accepted Answer

no, according to the latest financial statements, Paradigm Biopharmaceuticals Ltd has a net loss of $-18

Question 5

Does Paradigm Biopharmaceuticals Ltd have any liabilities?

Accepted Answer

yes, Paradigm Biopharmaceuticals Ltd has liability of 3

Question 6

How many outstanding shares for Paradigm Biopharmaceuticals Ltd?

Accepted Answer

Paradigm Biopharmaceuticals Ltd has a total outstanding shares of 389.42

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	7	7	6	8	7	8
Revenue Growth (YoY)	17%	17%	-25%	14%	-13%	100%
Cost of Revenue	0	0	0	0	0	0
Gross Profit	7	7	6	8	7	8
Selling, General & Admin	5	5	6	7	8	9
Research & Development	17	17	58	52	39	33
Operating Expenses	23	23	65	60	47	43
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-18	-18	-58	-51	-39	-34
Income Tax Expense	0	0	0	0	0	0
Net Income	-18	-18	-58	-51	-39	-34
Net Income Growth	-69%	-69%	14%	31%	15%	183%
Shares Outstanding (Diluted)	424.81	389.42	350.36	289.66	240.94	212.17
Shares Change (YoY)	6%	11%	21%	20%	14%	5%
EPS (Diluted)	-0.04	-0.04	-0.16	-0.17	-0.16	-0.16
EPS Growth	-66%	-71%	-6%	10%	1%	166%
Free Cash Flow	-15	-15	-65	-45	-32	-34
Free Cash Flow Per Share	-0.03	-0.03	-0.18	-0.15	-0.13	-0.16
Gross Margin	100%	100%	100%	100%	100%	100%
Operating Margin	-228.57%	-228.57%	-966.66%	-637.5%	-571.42%	-425%
Profit Margin	-257.14%	-257.14%	-966.66%	-637.5%	-557.14%	-425%
Free Cash Flow Margin	-214.28%	-214.28%	-1,083.33%	-562.5%	-457.14%	-425%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-16	-16	-58	-51	-40	-34
EBIT Margin	-228.57%	-228.57%	-966.66%	-637.5%	-571.42%	-425%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Paradigm Biopharmaceuticals Ltd (PBIGF) Price

PBIGF Stock Price Chart

PBIGF Income

Follow-Up Questions